| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vifa4g02468 | ATGTTTCTTCTTAGAAAGCAAACCCAGAATCAGCCAGAGAATGGTTCCTCAAATCATGATGCTAAGGTGGCTGAACTAAGAACTGCTATTGGGCCCTTATCCGGGCGTCGATTGATGTATTGCACAGATGCTTGTTTAAGGAGGTATTTAGAAGCACGGAATTGGAATGTTGATAAAACCAAGAAAATGCTGGAAGAATCACTTAAGTGGAGATCTAGTTATAAGCCTGAGGAAATCCGTTGGGCTGAAGTAGCACATGAAGGCGAGACGGGGAAAGTATCTCGAGCTAACTTTCATGATAGACTTGGGAGGACAGTGCTTATTATGAGACCAGGGATGCAGAACACAGCATCACCCGAAAATAATATCAAGCATTTAGTCTATCTGTTGGAAAATGCTGTACTTAATCTTTCCGATGGTCAAGAACAAATGTCATGGTTGATAGACTTCACAGGATTTACATTTGGCACAAACATTGCTATTAAAACTGCTCGTGATATTATTCACATTTTACAAAACCACTATCCAGAAAGGCTTGCTATTGCTTTTCTGTATAATCCACCAAGAATATTTCAGGCTTTCTGGAAGGCTGTGAAATACTTCCTGGATCCCAAGACAGCCCAGAAGGTAAAGTTTGTTTATCTCAACAACAAAGACAGTGTGGAACTGATGAAATCACTCTTCGACATGGAAAACCTTCCTAGTGAATTTGGCGGAAAAGCTACTTTACAGTATGACCATGTAGAGTTCTCAAAGTTAATGACTGAGGATGATGCGAAAACTGCAAAGTTCTGGGGACTTAATGACGAGAAGCCCTTCACTACTAAGAATGGCCATGGCGGGGCAGAAGTAGCACCAGAACCAGTATAG | 870 | 0.4126 | MFLLRKQTQNQPENGSSNHDAKVAELRTAIGPLSGRRLMYCTDACLRRYLEARNWNVDKTKKMLEESLKWRSSYKPEEIRWAEVAHEGETGKVSRANFHDRLGRTVLIMRPGMQNTASPENNIKHLVYLLENAVLNLSDGQEQMSWLIDFTGFTFGTNIAIKTARDIIHILQNHYPERLAIAFLYNPPRIFQAFWKAVKYFLDPKTAQKVKFVYLNNKDSVELMKSLFDMENLPSEFGGKATLQYDHVEFSKLMTEDDAKTAKFWGLNDEKPFTTKNGHGGAEVAPEPV | 289 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vifa4g02468 | 289 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 81 | 245 | IPR001251 | - | |
| Vifa4g02468 | 289 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 8 | 82 | IPR036273 | - | |
| Vifa4g02468 | 289 | MobiDBLite | consensus disorder prediction | 1 | 20 | - | - | |
| Vifa4g02468 | 289 | PANTHER | GH16843P | 8 | 270 | - | - | |
| Vifa4g02468 | 289 | CDD | SEC14 | 99 | 240 | IPR001251 | - | |
| Vifa4g02468 | 289 | Pfam | CRAL/TRIO domain | 98 | 239 | IPR001251 | - | |
| Vifa4g02468 | 289 | Pfam | CRAL/TRIO, N-terminal domain | 35 | 66 | IPR011074 | - | |
| Vifa4g02468 | 289 | SMART | sec14_4 | 87 | 242 | IPR001251 | - | |
| Vifa4g02468 | 289 | Gene3D | - | 3 | 273 | IPR036865 | - | |
| Vifa4g02468 | 289 | FunFam | Phosphatidylinositol transfer protein 3 | 3 | 273 | - | - | |
| Vifa4g02468 | 289 | SMART | CRAL_TRIO_N_2 | 42 | 67 | IPR011074 | - | |
| Vifa4g02468 | 289 | MobiDBLite | consensus disorder prediction | 1 | 18 | - | - | |
| Vifa4g02468 | 289 | SUPERFAMILY | CRAL/TRIO domain | 82 | 256 | IPR036865 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vifa4g02468 | Vifa-Chr4 | 743488483 | 743490996 | Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vifa4g02468 | 46 | 234 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 27.805 | 2.21e-11 | 61.6 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vifa4g02468 | K26544 | - | gmx:100800024 | 499.204 |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Vifa4g02468 | 4 | 743488483 | 743490996 | Vifa4g02468 | 4 | 743488483 | 743490996 | ECH |